Incidence of adverse events in antipsychotic-naïve children and adolescents treated with antipsychotic drugs: a French multicentre naturalistic study protocol (ETAPE) - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue BMJ Open Année : 2016

Incidence of adverse events in antipsychotic-naïve children and adolescents treated with antipsychotic drugs: a French multicentre naturalistic study protocol (ETAPE)

Résumé

Introduction: In France, over recent years, the prescription rate of antipsychotic (AP) remained stable in children and adolescents. Prescription of second-generation antipsychotics increased, whereas prescription of first-generation antipsychotics decreased. Off-label prescriptions are very frequent in this population. Adverse events (AEs) in youth treated with AP are common and may be severe. AEs have hitherto been poorly monitored in naturalistic studies independent from industry. Method and analysis: We describe a French prospective multicentre study in an AP-naïve paediatric population named Etude de la Tolérance des AntiPsychotique chez l'Enfant (ETAPE). The study started in April 2013. So far, 200 patients have been included. The inclusion criteria are: male or female inpatients aged from 6 to 18 years, treated with an AP drug for less than 28 days, never been treated or having received AP for less than 3 months, discontinued at least 6 months prior to inclusion. These assessments of AE are performed at inclusion, as well as at 3, 6, 9 and 12 months after the introduction of the AP. The monitoring period will end in May 2016. Ethics and dissemination: The study protocol was approved by the Ethics Committee 'Sud Méditerrané V' (number 12.082) and by the French National Agency for Medicines and Health Products Safety (number 2012-004546-15). All patients and their parents signed informed consent on enrolment in the study. We will submit the results of the study to relevant journals and offer national and international presentations. This study will enable better characterisation of the prescription of AP drugs. The results will further help to develop quality standards and recommendations for monitoring AE during the prescription of AP.
Fichier principal
Vignette du fichier
BMJ Open-2016-Menard-.pdf (909.65 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-01333954 , version 1 (20-06-2016)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Marie-Line Menard, Susanne Thümmler, Marianna Giannitelli, Bertrand Olliac, Olivier Bonnot, et al.. Incidence of adverse events in antipsychotic-naïve children and adolescents treated with antipsychotic drugs: a French multicentre naturalistic study protocol (ETAPE) . BMJ Open, 2016, 6 (4), pp.e011020. ⟨10.1136/bmjopen-2015-011020⟩. ⟨hal-01333954⟩
274 Consultations
225 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More